608
Views
279
CrossRef citations to date
0
Altmetric
Review

Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes

&
Pages 441-451 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (15)

Arya Sajayan, Amrudha Ravindran, Joseph Selvin, Prathiviraj Ragothaman & George Seghal Kiran. (2023) An antimicrobial metabolite n- hexadecenoic acid from marine sponge-associated bacteria Bacillus subtilis effectively inhibited biofilm forming multidrug-resistant P. aeruginosa. Biofouling 39:5, pages 502-515.
Read now
Pownraj Brindangnanam, Ajit Ramesh Sawant, K. Prashanth & Mohane Selvaraj Coumar. (2022) Bacterial effluxome as a barrier against antimicrobial agents: structural biology aspects and drug targeting. Tissue Barriers 10:4.
Read now
Sanchita Mitra, Tushar Agarwal, Abhijit Naik, Tapas Ranjan Padhi, Soumyava Basu & Umesh Chandra Behera. (2021) Post-Traumatic Endophthalmitis: Clinico-Microbiological Profile, Antimicrobial Susceptibility and Prognostic Factors at a Tertiary Eye Care Centre in Eastern India. Seminars in Ophthalmology 36:8, pages 742-750.
Read now
Qiushi Wang, Dapeng Hou, Jing Wang, Kai An, Chenghe Han & Chunting Wang. (2019) Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study. Infection and Drug Resistance 12, pages 815-824.
Read now
Mariadelfina Molinaro, Paola Morelli, Manuela De Gregori, Simona De Gregori, Ilaria Giardini, Federica Tordato, Vincenzina Monzillo, Daria Pocaterra & Erminia Casari. (2018) Efficacy of intraventricular amikacin treatment in pan-resistant Pseudomonas aeruginosa postsurgical meningitis. Infection and Drug Resistance 11, pages 1369-1372.
Read now
Pradeep Pushparaj Selvadoss, Jayshree Nellore, Malathy Balaraman Ravindrran, Uma Sekar & Jayakrishna Tippabathani. (2018) Enhancement of antimicrobial activity by liposomal oleic acid-loaded antibiotics for the treatment of multidrug-resistant Pseudomonas aeruginosa. Artificial Cells, Nanomedicine, and Biotechnology 46:2, pages 268-273.
Read now
Alberto Enrico Maraolo, Marco Cascella, Silvia Corcione, Arturo Cuomo, Salvatore Nappa, Guglielmo Borgia, Francesco Giuseppe De Rosa & Ivan Gentile. (2017) Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art. Expert Review of Anti-infective Therapy 15:9, pages 861-871.
Read now
Ashraf A. Kadry, Fathy M. Serry, Amira M. El-Ganiny & Ahmed M. El-Baz. (2017) Integron occurrence is linked to reduced biocide susceptibility in multidrug resistant Pseudomonas aeruginosa. British Journal of Biomedical Science 74:2, pages 78-84.
Read now
Susan Zelasko, Andrzej Gorski & Krystyna Dabrowska. (2017) Delivering phage therapy per os: benefits and barriers. Expert Review of Anti-infective Therapy 15:2, pages 167-179.
Read now
Nada Mahmoud Aboulfotoh Hashish, Aleya Abdel Gawad Abbass & Amira Ezzat Khamis Amine. (2017) Pseudomonas aeruginosa in swimming pools. Cogent Environmental Science 3:1.
Read now
Stephanie E Giancola, Monica V Mahoney, Tiffany E Bias & Elizabeth B Hirsch. (2016) Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections. Therapeutics and Clinical Risk Management 12, pages 787-797.
Read now
Abrar K Thabit, Jared L Crandon & David P Nicolau. (2015) Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials. Expert Opinion on Pharmacotherapy 16:2, pages 159-177.
Read now
Boris Pejin, Aleksandra Talevska, Ana Ciric, Jasmina Glamoclija, Milos Nikolic, Trajce Talevski & Marina Sokovic. (2014) Anti-quorum sensing activity of selected sponge extracts: a case study of Pseudomonas aeruginosa. Natural Product Research 28:24, pages 2330-2333.
Read now
Virginie Vitrat, Serge Hautefeuille, Cécile Janssen, David Bougon, Michel Sirodot & Leonardo Pagani. (2014) Optimizing antimicrobial therapy in critically ill patients. Infection and Drug Resistance 7, pages 261-271.
Read now
Giovanni Battista Orsi, Marco Falcone & Mario Venditti. (2011) Surveillance and management of multidrug-resistant microorganisms. Expert Review of Anti-infective Therapy 9:8, pages 653-679.
Read now

Articles from other publishers (264)

Kamal Uddin Zaidi, Fatema Shah & Firoz Naem Khan. (2024) Potential Synergistic Effect of F.carica Against P. aeruginosa Intended for the Management of Nosocomial Infection. Current Drug Therapy 19:1, pages 81-87.
Crossref
Nur Shazlin Shek Daud, Mark Dunn, Olga Lucia Moncayo-Nieto & Alasdair Hay. (2023) Is the combination of UV-C light and bleach less effective than bleach alone for intensive care unit surface disinfection?. Infection Prevention in Practice 5:4, pages 100307.
Crossref
Chris R. Proctor, Megan G. Taggart, Barry M.G. O'Hagan, Paul A. McCarron, Ronan R. McCarthy & Nigel G. Ternan. (2023) Furanone loaded aerogels are effective antibiofilm therapeutics in a model of chronic Pseudomonas aeruginosa wound infection. Biofilm 5, pages 100128.
Crossref
Tra-My Hoang, Weiliang Huang, Jonathan Gans, Jacob Weiner, Evan Nowak, Mariette Barbier, Angela Wilks, Maureen A. Kane & Amanda G. Oglesby. (2023) The heme-responsive PrrH sRNA regulates Pseudomonas aeruginosa pyochelin gene expression . mSphere 8:5.
Crossref
Jing Dang, Jian Shu, Ruiying Wang, Hanjie Yu, Zhuo Chen, Wenbo Yan, Bingxiang Zhao, Li Ding, Yuzi Wang, Huizheng Hu & Zheng Li. (2023) The glycopatterns of Pseudomonas aeruginosa as a potential biomarker for its carbapenem resistance . Microbiology Spectrum.
Crossref
Lixia He, Shanlin YangWeijun XuanXiumei ZhenQi QiYongqi QiQingxiang LiMeixia DuMichael R. Hamblin & Liyi Huang. (2023) Phenylalanine-Arginine-β-Naphthylamide Enhances the Photobactericidal Effect of Methylene Blue on Pseudomonas aeruginosa . Photobiomodulation, Photomedicine, and Laser Surgery 41:10, pages 569-575.
Crossref
Joana Admella & Eduard Torrents. (2023) Investigating bacterial infections in Galleria mellonella larvae: Insights into pathogen dissemination and behavior. Journal of Invertebrate Pathology 200, pages 107975.
Crossref
Ashish Kothari, Radhika Kherdekar, Vishal Mago, Madhur Uniyal, Garima Mamgain, Roop Bhushan Kalia, Sandeep Kumar, Neeraj Jain, Atul Pandey & Balram Ji Omar. (2023) Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa. Pharmaceuticals 16:9, pages 1230.
Crossref
Jiangsong Bai, Xiao Wang, Zihui Zhang, Pengjing Lian & Jian Qiao. (2023) Overview of Mink Immunity and Resistance to Pseudomonas aeruginosa. Veterinary Medicine International 2023, pages 1-9.
Crossref
Sepideh Fereshteh, Fatemeh Haririzadeh Jouriani, Narjes Noori Goodarzi, Mahdi Torkamaneh, Behnoush Khasheii & Farzad Badmasti. (2023) Defeating a superbug: A breakthrough in vaccine design against multidrug-resistant Pseudomonas aeruginosa using reverse vaccinology. PLOS ONE 18:8, pages e0289609.
Crossref
Camilla Filippi dos Santos Alves, Pauline Cordenonsi Bonez, Camila Casagrande, Dariane Jornada Clerici, Camila Marina Verdi, Carolina Gonzalez Urquhart, Marcos Vinicius Missel, Thais Barin, Roberto Christ Vianna Santos & e Marli Matiko Anraku de Campos. (2023) Antibiofilm activity of Equisetum hyeamale: interference with quorum sensing. Journal of Herbal Medicine, pages 100688.
Crossref
Sukesh Kumar Bajire, Ashwini Prabhu, Yashodhar P. Bhandary, K. M. Irfan & Rajesh P. Shastry. (2023) 7-Ethoxycoumarin rescued Caenorhabditis elegans from infection of COPD derived clinical isolate Pseudomonas aeruginosa through virulence and biofilm inhibition via targeting Rhl and Pqs quorum sensing systems. World Journal of Microbiology and Biotechnology 39:8.
Crossref
Jungmi Park, Neel Mahida, Gabrielle Ho, Elizabeth Pena, Jessa Marie V. Makabenta, Stanley Aneke, Mingdi Jiang, Leah M. Bouthillette, Stephanie E. Holz, Muhammad Aamir Hassan, Amanda L. Wolfe & Vincent M. Rotello. (2023) Integration of Antimicrobials and Delivery Systems: Synergistic Antibiofilm Activity with Biodegradable Nanoemulsions Incorporating Pseudopyronine Analogs. Antibiotics 12:8, pages 1240.
Crossref
Deinmo Edi, Ovinuchi Ejiohuo & Best Ordinioha. (2023) Occurrence and prevalence of bacteria on door handles at the University of Port Harcourt Teaching Hospital and the multidrug resistance implications. Access Microbiology 5:7.
Crossref
Berat ÖZKAN & Fatma BUDAK. (2023) Investigation of Virulence Factors and Antibiotic Resistance of Pseudomonas aeruginosa Isolated from A Range of Clinical Samples. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 9:2, pages 137-143.
Crossref
Ajay Guru, Raghul Murugan & Jesu Arockiaraj. (2023) Histone acetyltransferases derived RW20 protects and promotes rapid clearance of Pseudomonas aeruginosa in zebrafish larvae. International Microbiology.
Crossref
Rana Kadhim Mohammed, Karam D. Salman & Heba K. Tawfeeq. (2023) Molecular detection and gene expression of carbapenemase (blakpc) encoding gene of Klebsiella pneumonae isolated from clinical samples.. Bionatura 8:2, pages 1-9.
Crossref
Yash S. Raval, Derek Fleming, Abdelrhman Mohamed, Melissa J. Karau, Jayawant N. Mandrekar, Audrey N. Schuetz, Kerryl E. Greenwood‐Quaintance, Haluk Beyenal & Robin Patel. (2023) In Vivo Activity of Hydrogen‐Peroxide Generating Electrochemical Bandage Against Murine Wound Infections. Advanced Therapeutics 6:5.
Crossref
Ming-Ying Ai, Huai-En Lu, Wan-Yu Lee, Hsin-Yi Liu, Han-Chuan Chuang, Bi-Li Chen, Er-Ying Wang, Li-Hsin Tsao & Yuarn-Jang Lee. (2023) Development of a combination antibiogram for empirical treatments of Pseudomonas aeruginosa at a university-affiliated teaching hospital. Journal of Microbiology, Immunology and Infection 56:2, pages 344-350.
Crossref
Tatsuya Shirai, Mao Akagawa, Miho Makino, Manami Ishii, Ayaka Arai, Norika Nagasawa, Mitsuru Sada, Ryusuke Kimura, Kaori Okayama, Taisei Ishioka, Haruyuki Ishii, Shinichiro Hirai, Akihide Ryo, Haruyoshi Tomita & Hirokazu Kimura. (2023) Molecular Evolutionary Analyses of the Pseudomonas-Derived Cephalosporinase Gene. Microorganisms 11:3, pages 635.
Crossref
Sonia Quddus, Zainab Liaqat, Sadiq Azam, Mahboob Ul Haq, Sajjad Ahmad, Metab Alharbi & Ibrar Khan. (2023) Identification of Efflux Pump Mutations in Pseudomonas aeruginosa from Clinical Samples. Antibiotics 12:3, pages 486.
Crossref
Joanna A. Quaye & Giovanni Gadda. (2023) The Pseudomonas aeruginosa PAO1 metallo flavoprotein d-2-hydroxyglutarate dehydrogenase requires Zn2+ for substrate orientation and activation. Journal of Biological Chemistry 299:3, pages 103008.
Crossref
Francisco Salvà-Serra, Daniel Jaén-Luchoro, Nachiket P. Marathe, Ingegerd Adlerberth, Edward R. B. Moore & Roger Karlsson. (2023) Responses of carbapenemase-producing and non-producing carbapenem-resistant Pseudomonas aeruginosa strains to meropenem revealed by quantitative tandem mass spectrometry proteomics. Frontiers in Microbiology 13.
Crossref
Goutam Chowdhury, Bhabatosh Das, Shakti Kumar, Archana Pant, Priyadarshini Mukherjee, Debjani Ghosh, Hemanta Koley, Shin-ichi Miyoshi, Keinosuke Okamoto, Alapan Paul, Shanta Dutta, Thandavarayan Ramamurthy & Asish K Mukhopadyay. (2023) Genomic insights into extensively drug-resistant Pseudomonas aeruginosa isolated from a diarrhea case in Kolkata, India . Future Microbiology 18:3, pages 173-186.
Crossref
Joey Kuok Hoong Yam, Leon Zhen Wei Tan, Ziyan Hong, May Margarette Santillan Salido, Bau Yi Woo, Adeline Mei Hui Yong, Casandra Ai Zhu Tan, Sam Fong Yau Li, Liang Yang, Michael Givskov & Shu-Sin Chng. (2023) Auranofin inhibits virulence pathways in Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry 79, pages 117167.
Crossref
Margaux Frigoli, Joseph W. Lowdon, Manlio Caldara, Rocio Arreguin-Campos, Julia Sewall, Thomas J. Cleij, Hanne Diliën, Kasper Eersels & Bart van Grinsven. (2023) Thermal Pyocyanin Sensor Based on Molecularly Imprinted Polymers for the Indirect Detection of Pseudomonas aeruginosa . ACS Sensors 8:1, pages 353-362.
Crossref
Sherif A. El-Kafrawy, Aymn T. Abbas, Christopher Oelkrug, Marwa Tahoon, Sameera Ezzat, Alimuddin Zumla & Esam I. Azhar. (2023) IgY antibodies: The promising potential to overcome antibiotic resistance. Frontiers in Immunology 14.
Crossref
Inês Leonor Leitão, Carla Mimoso Santos, Paulo André, Sara Lino, Marcos Lemos & Filipe Froes. (2023) Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis. Enfermedades infecciosas y microbiologia clinica (English ed.).
Crossref
Truc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, Travis J Carlson, Faris Alnezary, William R Miller, Aki Sakurai, An Q Dinh, Kirsten Rydell, Rafael Rios, Lorena Diaz, Blake M Hanson, Jose M Munita, Claudia Pedroza, Samuel A Shelburne, Samuel L Aitken, Kevin W Garey, Ryan Dillon, Laura Puzniak & Cesar A Arias. (2023) Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA. JAC-Antimicrobial Resistance 5:1.
Crossref
Serge Eyebe, Hugues C. Nana-Djeunga, Magellan Guewo-Fokeng, Guy Sadeu Wafeu, Marius Zambou Vouking, Salomon Massoda, Christine D. Evina, Aurelia Condomat Zoumabo, Pierre Ongolo-Zogo & Jean-Ralph Zahar. (2022) Risk factors for colonization and infection with multidrug-resistant Pseudomonas aeruginosa in intensive care unit: protocol for a systematic review and meta-analysis. Systematic Reviews 11:1.
Crossref
Mariana Castanheira, Timothy B. Doyle, Cory M. Hubler, Timothy D. Collingsworth, Sean DeVries & Rodrigo E. Mendes. (2022) The plethora of resistance mechanisms in Pseudomonas aeruginosa: transcriptome analysis reveals a potential role of lipopolysaccharide pathway proteins to novel β-lactam/β-lactamase inhibitor combinations. Journal of Global Antimicrobial Resistance 31, pages 72-79.
Crossref
Sibylle H. Lob, Mark A. Estabrook, C. Andrew DeRyke, Irina Alekseeva, Fakhar Siddiqui, Katherine Young, Mary R. Motyl & Daniel F. Sahm. (2022) Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020. International Journal of Infectious Diseases 125, pages 250-257.
Crossref
Qin Dou, Jin Yuan, Rilei Yu, Jiahui Yang, Jiayi Wang, Yuxiang Zhu, Jing Zhong, Hongan Long, Zhiqing Liu, Xianghong Wang, Yuying Li, Yichen Xiao, Jiazhen Liang, Xiao‐Hua Zhang & Yan Wang. (2022) MomL inhibits bacterial antibiotic resistance through the starvation stringent response pathway. mLife 1:4, pages 428-442.
Crossref
Albane Jouault, Alessandra Mattos Saliba & Lhousseine Touqui. (2022) Modulation of the immune response by the Pseudomonas aeruginosa type-III secretion system. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Haley J. Appaneal, Aisling R. Caffrey, Vrishali Lopes, Emily C. Piehl, Laura A. Puzniak & Kerry L. LaPlante. (2022) Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa. Microbiology Spectrum 10:5.
Crossref
Nuoyan Wang, Xuemin Chen, Jing Luo, Fei Deng, Fuguo Shi, Qin Wu, Yasi Huang, Qin Ouyang, Rongxin Qin & Hong Zhou. (2022) Artemisinin derivative DHA27 enhances the antibacterial effect of aminoglycosides against Pseudomonas aeruginosa by inhibiting mRNA expression of aminoglycoside-modifying enzymes. Frontiers in Pharmacology 13.
Crossref
Ashlan J. Kunz Coyne, Mohammad Alshaer, Anthony M. Casapao, Veena Venugopalan, Carmen Isache, Jason Ferreira & Christopher A. Jankowski. (2022) Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection. Antimicrobial Agents and Chemotherapy 66:10.
Crossref
Adila Nazli, David L. He, Dandan Liao, Muhammad Zafar Irshad Khan, Chao Huang & Yun He. (2022) Strategies and progresses for enhancing targeted antibiotic delivery. Advanced Drug Delivery Reviews 189, pages 114502.
Crossref
Ghasem Ghorbani, Ebrahim Rahimi & Amir Shakerian. (2022) Antibiotic resistance’s Genotypic and Phenotypic Characteristics and the Frequency of Virulence Factors in P. aeruginosa Isolates Isolated from Water Samples in Iran. BioMed Research International 2022, pages 1-7.
Crossref
Peng Zhou, Brittny L. Garcia & Georgios A. Kotsakis. (2022) Comparison of antibacterial and antibiofilm activity of bioactive glass compounds S53P4 and 45S5. BMC Microbiology 22:1.
Crossref
Chung-Jong Kim, Kyoung-Ho Song, Nam-Kyong Choi, Jeonghoon Ahn, Ji Yun Bae, Hee Jung Choi, Younghee Jung, Seung Soon Lee, Ji-Hwan Bang, Eu Suk Kim, Song Mi Moon, Je Eun Song, Yee Gyung Kwak, Shin Hye Chun, Yeon-Sook Kim, Kyung-Hwa Park, Yu Min Kang, Pyoeng Gyun Choe, Shinwon Lee, Hong Bin Kim, Sang Won Park, Chan Mi Lee, Sook-In Jung, Seong Eun Kim, Wan Beom Park, Nam Joong Kim, Sun Hee Lee, Hyunju Lee, Jeong Su Park & Young-Jun Kim. (2022) Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea. Scientific Reports 12:1.
Crossref
Sarika Suresh, Kattapuni Suresh Prithvisagar, Ballamoole Krishna Kumar & Ramya Premanath. (2022) Unravelling the Distinctive Virulence Traits and Clonal Relationship among the Pseudomonas aeruginosa Isolates from Diabetic Patients. Journal of Pure and Applied Microbiology.
Crossref
Karina Tuz, Ming Yuan, Yuyao Hu, Tien T.T. Do, Soohaeng Yoo Willow, Joseph A. DePaolo-Boisvert, James R. Fuller, David D.L. Minh & Oscar Juárez. (2022) Identification of the riboflavin cofactor-binding site in the Vibrio cholerae ion-pumping NQR complex: A novel structural motif in redox enzymes. Journal of Biological Chemistry 298:8, pages 102182.
Crossref
Delia Boffoli, Federica Bellato, Greta Avancini, Pratik Gurnani, Gokhan Yilmaz, Manuel Romero, Shaun Robertson, Francesca Moret, Federica Sandrelli, Paolo Caliceti, Stefano Salmaso, Miguel Cámara, Giuseppe Mantovani & Francesca Mastrotto. (2021) Tobramycin-loaded complexes to prevent and disrupt Pseudomonas aeruginosa biofilms. Drug Delivery and Translational Research 12:8, pages 1788-1810.
Crossref
Qingquan Chen, Tejas Dharmaraj, Pamela C. Cai, Elizabeth B. Burgener, Naomi L. Haddock, Andy J. Spakowitz & Paul L. Bollyky. (2022) Bacteriophage and Bacterial Susceptibility, Resistance, and Tolerance to Antibiotics. Pharmaceutics 14:7, pages 1425.
Crossref
Fiorinda F. Muhaj, Saira J. George & Stephen K. Tyring. (2022) Bacterial antimicrobial resistance and dermatological ramifications*. British Journal of Dermatology 187:1, pages 12-20.
Crossref
Shivendra Dutt Shukla, Geeta Gupta, Razia Khatoon, Ritu Jain & Ankita Gupta. (2022) Biofilm Production and its Association with Multi Drug Resistance in Pseudomonas aeruginosa among ICU Patients with Special Reference to ESBL, AmpC and MBL production. Journal of Pure and Applied Microbiology 16:2, pages 858-866.
Crossref
Francis Rathinam Charles, Jit Xin Lim, Hongjie Chen, Shin Giek Goh, Yiliang He & Karina Yew-Hoong Gin. (2022) Prevalence and characterization of antibiotic resistant bacteria in raw community sewage from diverse urban communities. Science of The Total Environment 825, pages 153926.
Crossref
Shio-Shin Jean, Dorji Harnod & Po-Ren Hsueh. (2022) Global Threat of Carbapenem-Resistant Gram-Negative Bacteria. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Xi-kang Tang, Yu-bin Su, Hui-qing Ye, Zhen-yuan Dai, Huan Yi, Ke-xin Yang, Tian-tuo Zhang & Zhuang-gui Chen. (2022) Glucose-Potentiated Amikacin Killing of Cefoperazone/Sulbactam Resistant Pseudomonas aeruginosa. Frontiers in Microbiology 12.
Crossref
Julián Riaño-Moreno, Jhoana P. Romero-Leiton & Kernel Prieto. (2022) Contribution of Governance and Socioeconomic Factors to the P. aeruginosa MDR in Europe. Antibiotics 11:2, pages 212.
Crossref
Laura Corbella, Jorge Boán, Rafael San-Juan, Mario Fernández-Ruiz, Octavio Carretero, David Lora, Pilar Hernández-Jiménez, María Ruiz-Ruigómez, Isabel Rodríguez-Goncer, José Tiago Silva, Francisco López-Medrano, Manuel Lizasoain, Jennifer Villa, Jose Manuel Caro-Teller & José M. Aguado. (2022) Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa. International Journal of Antimicrobial Agents 59:2, pages 106517.
Crossref
Inês Leonor Leitão, Carla Mimoso Santos, Paulo André, Sara Lino, Marcos Lemos & Filipe Froes. (2022) Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis. Enfermedades Infecciosas y Microbiología Clínica.
Crossref
Ariadna Thalia Bernal-Mercado, Josué Juarez, Miguel Angel Valdez, Jesus Fernando Ayala-Zavala, Carmen Lizette Del-Toro-Sánchez & David Encinas-Basurto. (2022) Hydrophobic Chitosan Nanoparticles Loaded with Carvacrol against Pseudomonas aeruginosa Biofilms. Molecules 27:3, pages 699.
Crossref
Yinglu Wang, Qian Zheng, Li Li, Lile Pan & Hu Zhu. (2022) Anti-Quorum-Sensing Activity of Tryptophan-Containing Cyclic Dipeptides. Marine Drugs 20:2, pages 85.
Crossref
Mazen A. Sid Ahmed, Faisal Ahmad Khan, Hamad Abdel Hadi, Sini Skariah, Ali A. Sultan, Abdul Salam, Abdul Latif Al Khal, Bo Söderquist, Emad Bashir Ibrahim, Ali S. Omrani & Jana Jass. (2022) Association of blaVIM-2, blaPDC-35, blaOXA-10, blaOXA-488 and blaVEB-9 β-Lactamase Genes with Resistance to Ceftazidime–Avibactam and Ceftolozane–Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa. Antibiotics 11:2, pages 130.
Crossref
Bidemi Fashina & Youjun Deng. (2022) Smectite, sepiolite, and palygorskite for inactivation of pyocyanin, a biotoxin produced by drug-resistant Pseudomonas aeruginosa. Microporous and Mesoporous Materials 331, pages 111668.
Crossref
Mubashir Hussain, Xiaolong Liu, Shuming Tang, Jun Zou, Zhifei Wang, Zeeshan Ali, Nongyue He & Yongjun Tang. (2022) Rapid detection of Pseudomonas aeruginosa based on lab-on-a-chip platform using immunomagnetic separation, light scattering, and machine learning. Analytica Chimica Acta 1189, pages 339223.
Crossref
Jan Marco Kern. 2020. DGIM Innere Medizin. DGIM Innere Medizin 1 22 .
Barbara Rodriguez-Urretavizcaya, Nuria Pascual, Carme Pastells, Maria Teresa Martin-Gomez, Lluïsa Vilaplana & Maria-Pilar Marco. (2021) Diagnosis and Stratification of Pseudomonas aeruginosa Infected Patients by Immunochemical Quantitative Determination of Pyocyanin From Clinical Bacterial Isolates. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Nkechi V. Enwuru, Jason J. Gill, Katri P. Anttonen, Christian A. Enwuru, Ry. Young, Akinloye O. Coker & Jeffrey D. Cirillo. (2021) Isolation and characterization of novel phage (Podoviridae ɸParuNE1) and its efficacy against multi-drug-resistant Pseudomonas aeruginosa planktonic cells and biofilm. Beni-Suef University Journal of Basic and Applied Sciences 10:1.
Crossref
Tien Viet Dung Vu, Marc Choisy, Thi Thuy Nga Do, Van Minh Hoang Nguyen, James I. Campbell, Thi Hoi Le, Vu Trung Nguyen, Heiman F. L. Wertheim, Ngoc Thach Pham, Van Kinh Nguyen & H. Rogier van Doorn. (2021) Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016–2017. Antimicrobial Resistance & Infection Control 10:1.
Crossref
Abdulaziz AlqahtaniLondon MenaDean SchollCassandra KruczekJane A. Colmer-HamoodRandall M. JeterAbdul N. Hamood. (2021) Recombinant R2-pyocin cream is effective in treating Pseudomonas aeruginosa- infected wounds . Canadian Journal of Microbiology 67:12, pages 919-932.
Crossref
Y. Wang. (2021) Liposome as a delivery system for the treatment of biofilm‐mediated infections. Journal of Applied Microbiology 131:6, pages 2626-2639.
Crossref
Sabina Herrera, Marta Bodro & Alex Soriano. (2021) Predictors of multidrug resistant Pseudomonas aeruginosa involvement in bloodstream infections. Current Opinion in Infectious Diseases 34:6, pages 686-692.
Crossref
Yasir Adil Jabbar Alabdali. (2021) Detection and association of toxA gene with antibiotics resistance in Pseudomonas aeruginosa strains isolated from different sources in Al Muthanna city. Gene Reports 25, pages 101358.
Crossref
Jihyu Oh, So Yeon Park, Jin Seo Lee, Ji‐Young Park & Seo Hu Lee. (2021) Clinical characteristics and pathogens in percutaneous endoscopic gastrostomy site infection in patients with head and neck cancer: A 16‐year retrospective study. Laryngoscope Investigative Otolaryngology 6:6, pages 1325-1331.
Crossref
Jie Bai, Yian Huo, Xiucai Hu, Aijun Lü & Jingfeng Sun. (2021) Characterization of Pathogenic Pseudomonas alcaligenes Isolated from Koi Carp in China . Journal of Aquatic Animal Health 33:4, pages 243-251.
Crossref
Wenlu Zhang, Yaping Yuan, Shasha Li, Bo Deng, Jiaming Zhang & Zhongjie Li. (2021) Comparative transcription analysis of resistant mutants against four different antibiotics in Pseudomonas aeruginosa. Microbial Pathogenesis 160, pages 105166.
Crossref
Rayhane Ben-Khalifa, Frédéric Bustos Gaspar, Cristina Pereira, Leila Chekir-Ghedira & Soraya Rodríguez-Rojo. (2021) Essential Oil and Hydrophilic Antibiotic Co-Encapsulation in Multiple Lipid Nanoparticles: Proof of Concept and In Vitro Activity against Pseudomonas aeruginosa. Antibiotics 10:11, pages 1300.
Crossref
Aishwarya Vetrivel, Monica Ramasamy, Preethi Vetrivel, Santhi Natchimuthu, Shobana Arunachalam, Gon-Sup Kim & Rajeswari Murugesan. (2021) Pseudomonas aeruginosa Biofilm Formation and Its Control. Biologics 1:3, pages 312-336.
Crossref
Ahmed Nafis, Marcello Iriti, Lahcen Ouchari, Fatima El Otmani, Najat Marraiki, Abdallah M. Elgorban, Asad Syed, Noureddine Mezrioui, Lahcen Hassani & Luísa Custódio. (2021) New Insight into the Chemical Composition, Antimicrobial and Synergistic Effects of the Moroccan Endemic Thymus atlanticus (Ball) Roussine Essential Oil in Combination with Conventional Antibiotics. Molecules 26:19, pages 5850.
Crossref
Márió Gajdács, Zoltán Baráth, Krisztina Kárpáti, Dóra Szabó, Donatella Usai, Stefania Zanetti & Matthew Gavino Donadu. (2021) No Correlation between Biofilm Formation, Virulence Factors, and Antibiotic Resistance in Pseudomonas aeruginosa: Results from a Laboratory-Based In Vitro Study. Antibiotics 10:9, pages 1134.
Crossref
Mera A. Ababneh, Abeer M. Rababa'h, Basima A. Almomani, Abeer M. Ayoub & Sayer I. Al‐Azzam. (2021) A ten‐year surveillance of P aeruginosa bloodstream infections in a tertiary care hospital: Trends and risk factors for mortality . International Journal of Clinical Practice 75:9.
Crossref
Likaa H. Mahdi, Ali R. Laftah, Kadhim H. Yaseen, Ibtesam Ghadban Auda & Rajwa H. Essa. (2021) Establishing novel roles of bifidocin LHA, antibacterial, antibiofilm and immunomodulator against Pseudomonas aeruginosa corneal infection model. International Journal of Biological Macromolecules 186, pages 433-444.
Crossref
Zohreh Riahi Rad, Zahra Riahi Rad, Hossein Goudarzi, Mehdi Goudarzi, Mohammad Mahmoudi, Javad Yasbolaghi Sharahi & Ali Hashemi. (2021) MicroRNAs in the interaction between host–bacterial pathogens: A new perspective. Journal of Cellular Physiology 236:9, pages 6249-6270.
Crossref
Wafaa A. Abd El-Ghany. (2021) Pseudomonas aeruginosa infection of avian origin: Zoonosis and one health implications. Veterinary World, pages 2155-2159.
Crossref
Reese A. Cosimi, Zachary W. Howe & Lindsay M. Saum. (2020) Impact of Extended- Versus Intermittent-Infusion Cefepime on Clinical Outcomes in Hospitalized Patients. Hospital Pharmacy 56:4, pages 302-307.
Crossref
Aishwarya Vetrivel, Santhi Natchimuthu, Vidyalakshmi Subramanian & Rajeswari Murugesan. (2021) High-Throughput Virtual Screening for a New Class of Antagonist Targeting LasR of Pseudomonas aeruginosa . ACS Omega 6:28, pages 18314-18324.
Crossref
Rahman Laibi Chelab. 2021. Pseudomonas aeruginosa - Biofilm Formation, Infections and Treatments. Pseudomonas aeruginosa - Biofilm Formation, Infections and Treatments.
Diep The Tai, Nguyen Anh Quang, Nguyen Thi Ngoc Nhi & Le Ha Duc Anh. (2021) Application of bacteriophage cocktail to control multi-drug resistant Pseudomonas aeruginosa. Journal of Microbiology & Experimentation 9:3, pages 72-76.
Crossref
Constanza Toledo, Rocío C. Gambaro, Gisel Padula, María E. Vela, Guillermo R. Castro, Cecilia Y. Chain & Germán A. Islan. (2021) Binary Medical Nanofluids by Combination of Polymeric Eudragit Nanoparticles for Vehiculization of Tobramycin and Resveratrol: Antimicrobial, Hemotoxicity and Protein Corona Studies. Journal of Pharmaceutical Sciences 110:4, pages 1739-1748.
Crossref
Isaac Martin, Dervla T. D. Kenna, Sandra Morales, Eric W. F. W. Alton & Jane C. Davies. (2021) Variability in Bacteriophage and Antibiotic Sensitivity in Serial Pseudomonas aeruginosa Isolates from Cystic Fibrosis Airway Cultures over 12 Months. Microorganisms 9:3, pages 660.
Crossref
Biljana Mojsoska, Melanie Ghoul, Gabriel G. Perron, Håvard Jenssen & Fatima AlZahra’a Alatraktchi. (2021) Changes in toxin production of environmental Pseudomonas aeruginosa isolates exposed to sub-inhibitory concentrations of three common antibiotics. PLOS ONE 16:3, pages e0248014.
Crossref
Isaac Martin, Valerie Waters & Hartmut Grasemann. (2021) Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways. International Journal of Molecular Sciences 22:4, pages 2155.
Crossref
Christen E. SalyerChristina BomholtNadine BeckmannChristian B. BergmannCourtney A. PlattnerCharles C. Caldwell. (2021) Novel Therapeutics for the Treatment of Burn Infection. Surgical Infections 22:1, pages 113-120.
Crossref
Banafsheh Douzandeh-Mobarrez, Hesam Alizade, Hossein S. Kafil & Afsaneh Karmostaji. (2021) Antimicrobial categories in describing multidrug resistance, extensive drug resistance and pan-drug resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: a systematic review. Reviews in Medical Microbiology 32:1, pages 6-11.
Crossref
Rumman Zaidi & Ameer Azam. Investigation of structural, optical and antibacterial properties of zinc sulphide quantum dots prepared by sol-gel method. Investigation of structural, optical and antibacterial properties of zinc sulphide quantum dots prepared by sol-gel method.
Antonio Clemente, Alejandra Alba-Patiño, Estrella Rojo-Molinero, Steven M. Russell, Marcio Borges, Antonio Oliver & Roberto de la Rica. (2020) Rapid Detection of Pseudomonas aeruginosa Biofilms via Enzymatic Liquefaction of Respiratory Samples . ACS Sensors 5:12, pages 3956-3963.
Crossref
Leisha M. Armijo, Stephen J. Wawrzyniec, Michael Kopciuch, Yekaterina I. Brandt, Antonio C. Rivera, Nathan J. Withers, Nathaniel C. Cook, Dale L. Huber, Todd C. Monson, Hugh D. C. Smyth & Marek Osiński. (2020) Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms. Journal of Nanobiotechnology 18:1.
Crossref
Mustafa Elhag, Ruaa Mohamed Alaagib, Nagla Mohamed Ahmed, Mustafa Abubaker, Esraa Musa Haroun, Sahar Obi Abd Albagi & Mohammed A. Hassan. (2020) Design of Epitope-Based Peptide Vaccine against Pseudomonas aeruginosa Fructose Bisphosphate Aldolase Protein Using Immunoinformatics. Journal of Immunology Research 2020, pages 1-11.
Crossref
Sandra Patricia Rivera-Sánchez, Helen Astrid Agudelo-Góngora, José Oñate-Garzón, Liliana Janeth Flórez-Elvira, Adriana Correa, Paola Andrea Londoño, Juan David Londoño-Mosquera, Alberto Aragón-Muriel, Dorian Polo-Cerón & Iván Darío Ocampo-Ibáñez. (2020) Antibacterial Activity of a Cationic Antimicrobial Peptide against Multidrug-Resistant Gram-Negative Clinical Isolates and Their Potential Molecular Targets. Molecules 25:21, pages 5035.
Crossref
Asma Khalid, Dongbi Bai, Amanda N. Abraham, Amit Jadhav, Denver Linklater, Alex Matusica, Duy Nguyen, Billy James Murdoch, Nadia Zakhartchouk, Chaitali Dekiwadia, Philipp Reineck, David Simpson, Achini K. Vidanapathirana, Shadi Houshyar, Christina A. Bursill, Elena P. Ivanova & Brant C. Gibson. (2020) Electrospun Nanodiamond–Silk Fibroin Membranes: A Multifunctional Platform for Biosensing and Wound-Healing Applications. ACS Applied Materials & Interfaces 12:43, pages 48408-48419.
Crossref
Agnieszka Jabłońska-Wawrzycka, Patrycja Rogala, Grzegorz Czerwonka, Sławomir Michałkiewicz, Maciej Hodorowicz & Paweł Kowalczyk. (2020) Ruthenium(IV) Complexes as Potential Inhibitors of Bacterial Biofilm Formation. Molecules 25:21, pages 4938.
Crossref
Olga Pappa, Anastasia Maria Kefala, Kyriaki Tryfinopoulou, Marios Dimitriou, Kostas Kostoulas, Chrysa Dioli, Eleni Moraitou, Maria Panopoulou, Evaggelos Vogiatzakis, Athena Mavridou, Alex Galanis & Apostolos Beloukas. (2020) Molecular Epidemiology of Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Hospitalized Patients in Greece. Microorganisms 8:11, pages 1652.
Crossref
Yasaman Ahmadbeigi, Alireza Salimi Chirani, Neda Soleimani, Mehdi Mahdavi & Mehdi Goudarzi. (2020) Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: A combination of immunoinformatics investigation and active immunization. Molecular Immunology 124, pages 70-82.
Crossref
Ding-Ding Guo, Li-Ming Luo, Hai-Long Ma, Si-Ping Zhang, Hang Xu, Honghua Zhang, Yong Wang, Yongna Yuan, Zhen Wang & Yong-Xing He. (2020) The Regulator PltZ Regulates a Putative ABC Transporter System PltIJKNOP of Pseudomonas aeruginosa ATCC 27853 in Response to the Antimicrobial 2,4-Diacetylphloroglucinol. Frontiers in Microbiology 11.
Crossref
Eliott Jacopin, Sonja Lehtinen, Florence Débarre & François Blanquart. (2020) Factors favouring the evolution of multidrug resistance in bacteria. Journal of The Royal Society Interface 17:168, pages 20200105.
Crossref
Hossein Karballaei MirzahosseiniMehdi Hadadi-FishaniKorosh MorshediAzad Khaledi. (2020) Meta-Analysis of Biofilm Formation, Antibiotic Resistance Pattern, and Biofilm-Related Genes in Pseudomonas aeruginosa Isolated from Clinical Samples . Microbial Drug Resistance 26:7, pages 815-824.
Crossref
Wimonrut Insuan & Thippayarat Chahomchuen. (2020) Chemical Composition and Antimicrobial Activity of Essential Oil Extracted from Eucalyptus citriodora Leaf. Microbiology and Biotechnology Letters 48:2, pages 148-157.
Crossref
Libo Li, Stephanie O. Palmer, Elizabeth A. Gomez, Frank Mendiola, Tianzhi Wang, James M. Bullard & Yonghong Zhang. (2020) 1H, 13C and 15N resonance assignments of translation initiation factor 3 from Pseudomonas aeruginosa. Biomolecular NMR Assignments 14:1, pages 93-97.
Crossref
Sarah C. J. Jorgensen, Trang D. Trinh, Evan J. Zasowski, Abdalhamid M. Lagnf, Samuel P. Simon, Sahil Bhatia, Sarah M. Melvin, Molly E. Steed, Natalie A. Finch, Taylor Morrisette, Sandy J. Estrada, Joshua R. Rosenberg, Susan L. Davis & Michael J. Rybak. (2020) Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrobial Agents and Chemotherapy 64:4.
Crossref
Adrian Cazares, Matthew P. Moore, James P.  J. Hall, Laura L. Wright, Macauley Grimes, Jean-Guillaume Emond-Rhéault, Pisut Pongchaikul, Pitak Santanirand, Roger C. Levesque, Joanne L. Fothergill & Craig Winstanley. (2020) A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas. Nature Communications 11:1.
Crossref
Mohammad Darvishi, Mojgan Forootan, Mohammad Reza Nazer, Ebrahim Karimi & Majid Noori. (2020) Nosocomial Infections, Challenges and Threats: A Review Article. Iranian Journal of Medical Microbiology 14:2, pages 162-181.
Crossref
Patrick R. Secor, Elizabeth B. Burgener, M. Kinnersley, Laura K. Jennings, Valery Roman-Cruz, Medeea Popescu, Jonas D. Van Belleghem, Naomi Haddock, Conner Copeland, Lia A. Michaels, Christiaan R. de Vries, Qingquan Chen, Julie Pourtois, Travis J. Wheeler, Carlos E. Milla & Paul L. Bollyky. (2020) Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections. Frontiers in Immunology 11.
Crossref
Azam Molapour, Amir Peymani, Parvaneh Saffarain, Narges Habibollah-Pourzereshki & Pooya Rashvand. (2020) Plasmid-Mediated Quinolone Resistance in Pseudomonas aeruginosa Isolated from Burn Patients in Tehran, Iran. Infectious Disorders - Drug Targets 20:1, pages 49-55.
Crossref
Ashish Kothari, Shailesh Kumar, BalramJi Omar & Kamini Kiran. (2020) Detection of extended-spectrum beta-lactamase (ESBL) production by disc diffusion method among Pseudomonas species from various clinical samples. Journal of Family Medicine and Primary Care 9:2, pages 683.
Crossref
FalahHasan Obayes AL-Khikani. (2020) Trends in antibiotic resistance of major uropathogens. Matrix Science Medica 4:4, pages 108.
Crossref
Yaser Hamadeh TaraziEhab A. Abu-BashaZuhair Bani IsmailRawan A. Tailony. (2020) In vitro and in vivo efficacy study of cefepime, doripenem, tigecycline, and tetracycline against extended-spectrum beta-lactamases Escherichia coli in chickens. Veterinary World 13:3, pages 446-451.
Crossref
Jesus Ruiz, Alejandra Ferrada, Miguel Salavert, Mónica Gordon, Esther Villarreal, Álvaro Castellanos-Ortega & Paula Ramirez. (2020) Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia . Dose-Response 18:1, pages 155932581988579.
Crossref
Iván Darío Ocampo-Ibáñez, Yamil Liscano, Sandra Patricia Rivera-Sánchez, José Oñate-Garzón, Ashley Dayan Lugo-Guevara, Liliana Janeth Flórez-Elvira & Maria Cristina Lesmes. (2020) A Novel Cecropin D-Derived Short Cationic Antimicrobial Peptide Exhibits Antibacterial Activity Against Wild-Type and Multidrug-Resistant Strains of Klebsiella pneumoniae and Pseudomonas aeruginosa . Evolutionary Bioinformatics 16, pages 117693432093626.
Crossref
Ian F. Akyildiz, Maysam Ghovanloo, Ulkuhan Guler, Tevhide Ozkaya-Ahmadov, A. Fatih Sarioglu & Bige D. Unluturk. (2020) PANACEA: An Internet of Bio-NanoThings Application for Early Detection and Mitigation of Infectious Diseases. IEEE Access 8, pages 140512-140523.
Crossref
Paramanantham Parasuraman, Asad Syed & Busi Siddhardha. 2020. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery 227 256 .
James A. Wroe, Christopher T. Johnson & Andrés J. García. (2019) Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo. Journal of Biomedical Materials Research Part A 108:1, pages 39-49.
Crossref
Warren Chanda, Mespa Manyepa, Ephraim Chikwanda, Victor Daka, Justin Chileshe, Mathias Tembo, Joseph Kasongo, Allen Chipipa, Ray Handema & John A. Mulemena. (2019) Evaluation of antibiotic susceptibility patterns of pathogens isolated from routine laboratory specimens at Ndola Teaching Hospital: A retrospective study. PLOS ONE 14:12, pages e0226676.
Crossref
Gabriel Torrens, Sara Belén Hernández, Juan Alfonso Ayala, Bartolome Moya, Carlos Juan, Felipe Cava & Antonio Oliver. (2019) Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling. mSystems 4:6.
Crossref
Ming Yang, Chunye Zhang, Sarah A. Hansen, William J. Mitchell, Michael Z. Zhang & Shuping Zhang. (2019) Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model. BMC Microbiology 19:1.
Crossref
Samuel J. T. Wardell, Attika Rehman, Lois W. Martin, Craig Winstanley, Wayne M. Patrick & Iain L. Lamont. (2019) A Large-Scale Whole-Genome Comparison Shows that Experimental Evolution in Response to Antibiotics Predicts Changes in Naturally Evolved Clinical Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 63:12.
Crossref
M.A. Sid Ahmed, A.A.I. Hassan, S. Abu Jarir, H. Abdel Hadi, D. Bansal, A. Abdul Wahab, M. Muneer, S.F. Mohamed, K. Zahraldin, J.M. Hamid, M.A. Alyazidi, M. Mohamed, A.A. Sultan, B. Söderquist, E.B. Ibrahim & J. Jass. (2019) Emergence of Multidrug- and Pandrug- Resistant Pseudomonas aeruginosa from Five Hospitals in Qatar. Infection Prevention in Practice 1:3-4, pages 100027.
Crossref
Sravan Kumar Miryala, Anand Anbarasu & Sudha Ramaiah. (2019) Systems biology studies in Pseudomonas aeruginosa PA01 to understand their role in biofilm formation and multidrug efflux pumps. Microbial Pathogenesis 136, pages 103668.
Crossref
Juan P. Horcajada, Milagro Montero, Antonio Oliver, Luisa Sorlí, Sònia Luque, Silvia Gómez-Zorrilla, Natividad Benito & Santiago Grau. (2019) Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections. Clinical Microbiology Reviews 32:4.
Crossref
Seyed Amin Enayatzadeh meymandi, Laleh Babaeekhou & Maryam Ghane. (2019) Distribution of Ambler Class A Β-lactamase Genes and Evaluation of Resistance Patterns in Multi-Drug and Extensively-Drug Resistant P. aeruginosa Clinical Isolates. Medical Laboratory Journal 13:5, pages 1-7.
Crossref
Chloe J Mitchell, Tracy A. Stone & Charles M. Deber. (2019) Peptide-Based Efflux Pump Inhibitors of the Small Multidrug Resistance Protein from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 63:9.
Crossref
Mariana Castanheira, Timothy B Doyle, Caitlin J Smith, Rodrigo E Mendes & Helio S Sader. (2019) Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals. Journal of Antimicrobial Chemotherapy 74:9, pages 2588-2595.
Crossref
Kacie E. Clark, Mary E. Briand, Om Kapoor & Ameen Pirasteh. (2018) Impact of a Standardized Beta-Lactam Allergy Questionnaire on Aztreonam Use. Journal of Pharmacy Practice 32:4, pages 399-403.
Crossref
Selvaraj Mohana Roopan, D. Devi Priya, S. Shanavas, R. Acevedo, Naif Abdullah Al-Dhabi & Mariadhas Valan Arasu. (2019) CuO/C nanocomposite: Synthesis and optimization using sucrose as carbon source and its antifungal activity. Materials Science and Engineering: C 101, pages 404-414.
Crossref
Likaa Hamied Mahdi, Hussein Satar Jabbar & Ibtesam Ghadban Auda. (2019) Antibacterial immunomodulatory and antibiofilm triple effect of Salivaricin LHM against Pseudomonas aeruginosa urinary tract infection model. International Journal of Biological Macromolecules 134, pages 1132-1144.
Crossref
Simon Frey, Tom Stargardt, Udo Schneider & Jonas Schreyögg. (2019) The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective. PharmacoEconomics 37:8, pages 1029-1039.
Crossref
Sara Saleh, An Staes, Stijn Deborggraeve & Kris Gevaert. (2019) Targeted Proteomics for Studying Pathogenic Bacteria. PROTEOMICS 19:16.
Crossref
Marguerite L. Monogue, Jennifer Tabor-Rennie, Kamilia Abdelraouf & David P. Nicolau. (2019) In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model . Antimicrobial Agents and Chemotherapy 63:7.
Crossref
Nooralden Al-Tulaibawi. (2019) Prevalence and Sensitivity of Bacterial Urinary Tract Infection among Adult Diabetic Patients in Misan Province, Iraq. Journal of Pure and Applied Microbiology 13:2, pages 847-853.
Crossref
Sankalp Malhotra, Don HayesJr.Jr. & Daniel J. Wozniak. (2019) Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface. Clinical Microbiology Reviews 32:3.
Crossref
R. Issa, N. Chanishvili, J. Caplin, E. Kakabadze, N. Bakuradze, K. Makalatia & I. Cooper. (2019) Antibiofilm potential of purified environmental bacteriophage preparations against early stage Pseudomonas aeruginosa biofilms . Journal of Applied Microbiology 126:6, pages 1657-1667.
Crossref
Rabeb Mouna Derbali, Valery Aoun, Ghina Moussa, Giorgia Frei, Soudeh F. Tehrani, Juliana Campos Del’Orto, Patrice Hildgen, V. Gaëlle Roullin & Jeanne Leblond Chain. (2019) Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa : A Comparative Study . Molecular Pharmaceutics 16:5, pages 1906-1916.
Crossref
Mansour Amin, Samaneh Yousef pour & Tahereh Navidifar. (2019) Detection of the major bacterial pathogens among children suffering from empyema in Ahvaz city, Iran. Journal of Clinical Laboratory Analysis 33:4.
Crossref
Tyler Flockton, Logan Schnorbus, Agustin Araujo, Jill Adams, Maryjane Hammel & Lark Perez. (2019) Inhibition of Pseudomonas aeruginosa Biofilm Formation with Surface Modified Polymeric Nanoparticles. Pathogens 8:2, pages 55.
Crossref
Huixue Jia, Liuyi Li, Weiguang Li, Tieying Hou, Hongqiu Ma, Yun Yang, Anhua Wu, Yunxi Liu, Jianguo Wen, Huai Yang, Xiaoli Luo, Yawei Xing, Weihong Zhang, Yinghong Wu, Lili Ding, Weiping Liu, Ling Lin, Ying Li & Meilian Chen. (2019) Impact of Healthcare-Associated Infections on Length of Stay: A Study in 68 Hospitals in China. BioMed Research International 2019, pages 1-7.
Crossref
Abeer M Abd El-Aziz, Abdelaziz Elgaml & Youssif M Ali. (2019) Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa. The Journal of Infectious Diseases 219:9, pages 1439-1447.
Crossref
Oihana Basabe-BurgosJakub ZebialowiczGuido StichtenothTore CurstedtPeter BergmanJan JohanssonAnna Rising. (2019) Natural Derived Surfactant Preparation As a Carrier of Polymyxin E for Treatment of Pseudomonas aeruginosa Pneumonia in a Near-Term Rabbit Model . Journal of Aerosol Medicine and Pulmonary Drug Delivery 32:2, pages 110-118.
Crossref
Navin B. Patel, Asif R. Shaikh, Vatsal M. Patel, Edgar E. Lara-Ramirez & Gildardo Rivera. (2019) Benzothiazol Clubbed Imidazol-4-ones as Anti-fungal, Anti-tubercular and Anti-HIV-1 Agents: Their Synthesis and Molecular Docking Study. Letters in Drug Design & Discovery 16:4, pages 382-391.
Crossref
Lixin SunSuzhe LiuJingming WangLiqun Wang. (2019) Analysis of Risk Factors for Multiantibiotic-Resistant Infections Among Surgical Patients at a Children's Hospital. Microbial Drug Resistance 25:2, pages 297-303.
Crossref
Shin Giek Goh, Nazanin Saeidi, Xiaoqiong Gu, Genevieve Gabrielle Rose Vergara, Liang Liang, Haoming Fang, Masaaki Kitajima, Ariel Kushmaro & Karina Yew-Hoong Gin. (2019) Occurrence of microbial indicators, pathogenic bacteria and viruses in tropical surface waters subject to contrasting land use. Water Research 150, pages 200-215.
Crossref
Reyhaneh Shams Khozani, Delavar Shahbazzadeh, Naser Harzandi, Mohammad Mehdi Feizabadi & Kamran Pooshang Bagheri. (2018) Kinetics Study of Antimicrobial Peptide, Melittin, in Simultaneous Biofilm Degradation and Eradication of Potent Biofilm Producing MDR Pseudomonas aeruginosa Isolates. International Journal of Peptide Research and Therapeutics 25:1, pages 329-338.
Crossref
Lalit Kumar Gautam, Prince Sharma & Neena Capalash. (2019) Bacterial Polyphosphate Kinases Revisited: Role in Pathogenesis and Therapeutic Potential. Current Drug Targets 20:3, pages 292-301.
Crossref
Azam Malekian, Gholamreza Esmaeeli Djavid, Kamran Akbarzadeh, Mehdi Soltandallal, Yavar Rassi, Javad Rafinejad, Abbas Rahimi Foroushani, Amir Reza Farhoud, Ronak Bakhtiary & Mehrangiz Totonchi. (2019) Efficacy of Maggot Therapy on Staphylococcus aureus and Pseudomonas aeruginosa in Diabetic Foot Ulcers. Journal of Wound, Ostomy & Continence Nursing 46:1, pages 25-29.
Crossref
Zheng Pang, Renee Raudonis, Bernard R. Glick, Tong-Jun Lin & Zhenyu Cheng. (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnology Advances 37:1, pages 177-192.
Crossref
Manuel Ahumada, Erik J. Suuronen & Emilio I. Alarcon. 2019. Handbook of Ecomaterials. Handbook of Ecomaterials 3485 3501 .
Bogeum Kim, Min-Sung Kim, Seul-Ki Park, Seok-Chun Ko, Sung-Hwan Eom, Won-Kyo Jung & Young-Mog Kim. (2018) Antibacterial effect of Ishige okamurae extract against cutaneous bacterial pathogens and its synergistic antibacterial effect against Pseudomonas aeruginosa. Fisheries and Aquatic Sciences 21:1.
Crossref
Jamshid Faghri, Samereh Nouri, Saba Jalalifar, Mehrdad Zalipoor & Mehrdad Halaji. (2018) Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran. BMC Research Notes 11:1.
Crossref
Thana Khawcharoenporn, Alan Chuncharunee, Chailat Maluangnon, Thitiporn Taweesakulvashra & Pimsiri Tiamsak. (2018) Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia. International Journal of Antimicrobial Agents 52:6, pages 828-834.
Crossref
Mania Ackermann, Henning Kempf, Miriam Hetzel, Christina Hesse, Anna Rafiei Hashtchin, Kerstin Brinkert, Juliane Wilhelmine Schott, Kathrin Haake, Mark Philipp Kühnel, Silke Glage, Constanca Figueiredo, Danny Jonigk, Katherina Sewald, Axel Schambach, Sabine Wronski, Thomas Moritz, Ulrich Martin, Robert Zweigerdt, Antje Munder & Nico Lachmann. (2018) Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nature Communications 9:1.
Crossref
Helio S Sader, Robert K Flamm, Glenn E Dale, Paul R Rhomberg & Mariana Castanheira. (2018) Murepavadin activity tested against contemporary (2016–17) clinical isolates of XDR Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 73:9, pages 2400-2404.
Crossref
Selina Y.L. HolbrookSylvie Garneau-Tsodikova. (2018) Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates . Microbial Drug Resistance 24:7, pages 1020-1030.
Crossref
Lai Jiang, Jia Lin, Clifford C. Taggart, José A. Bengoechea & Christopher J. Scott. (2018) Nanodelivery strategies for the treatment of multidrug-resistant bacterial infections. Journal of Interdisciplinary Nanomedicine 3:3, pages 111-121.
Crossref
Yunhui Zhang, Andrea Sass, Heleen Van Acker, Jasper Wille, Bruno Verhasselt, Filip Van Nieuwerburgh, Volkhard Kaever, Aurélie Crabbé & Tom Coenye. (2018) Coumarin Reduces Virulence and Biofilm Formation in Pseudomonas aeruginosa by Affecting Quorum Sensing, Type III Secretion and C-di-GMP Levels. Frontiers in Microbiology 9.
Crossref
Valentina Grumezescu, Irina Negut, Alexandru Mihai Grumezescu, Anton Ficai, Gabriela Dorcioman, Gabriel Socol, Florin Iordache, Roxana Truşcă, Bogdan Stefan Vasile & Alina Maria Holban. (2018) MAPLE fabricated coatings based on magnetite nanoparticles embedded into biopolymeric spheres resistant to microbial colonization. Applied Surface Science 448, pages 230-236.
Crossref
N. Save & S. Deshpande. (2018) UPCOMING TRENDS TO COMBAT ANTIBIOTIC RESISTANCE. INDIAN DRUGS 55:07, pages 7-19.
Crossref
Payal K. Patel, Twisha S. Patel & Kaye Keith S.. (2018) Pseudomonas aeruginosa - Difficult to Outmanoeuvre. Indian Journal of Medical Microbiology 36:3, pages 301-302.
Crossref
Dong Ju Lee, A. Ra Jo, Min Cheol Jang, Jiyoung Nam, Hyun Jun Choi, Go-Woo Choi, Hye Yeong Sung, Hyungwoo Bae, Yang-Gyu Ku & Youn-Tae Chi. (2018) Analysis of two quorum sensing-deficient isolates of Pseudomonas aeruginosa. Microbial Pathogenesis 119, pages 162-169.
Crossref
Ramadan Hassan, Wael El-Naggar, Abeer M. Abd El-Aziz, Mona Shaaban, Hany I. Kenawy & Youssif M. Ali. (2018) Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Journal of Microbiology, Immunology and Infection 51:3, pages 312-320.
Crossref
Vincent H. Tam, Cynthia Pérez, Kimberly R. Ledesma & Russell E. Lewis. (2018) Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic-susceptible and multidrug-resistant Pseudomonas aeruginosa . Microbiology and Immunology 62:4, pages 291-294.
Crossref
Yamuna Devi Bakthavatchalam, Agila Kumari Pragasam, Indranil Biswas & Balaji Veeraraghavan. (2018) Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanisms: An update. Journal of Global Antimicrobial Resistance 12, pages 124-136.
Crossref
M. Molnar, M. Tomić & V. Pavić. (2018) Coumarinyl Thiosemicarbazides as Antimicrobial Agents. Pharmaceutical Chemistry Journal 51:12, pages 1078-1081.
Crossref
Nattawan Palavutitotai, Anupop Jitmuang, Sasima Tongsai, Pattarachai Kiratisin & Nasikarn Angkasekwinai. (2018) Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections. PLOS ONE 13:2, pages e0193431.
Crossref
Anna Proschak, Jan Kramer, Ewgenij Proschak & Thomas A Wichelhaus. (2018) Bacterial zincophore [S,S]-ethylenediamine-N,N′-disuccinic acid is an effective inhibitor of MBLs. Journal of Antimicrobial Chemotherapy 73:2, pages 425-430.
Crossref
Nandagopal Murugan, Jambulingam Malathi, K Lily Therese & Hajib NarahariRao Madhavan. (2017) Application of six multiplex PCR's among 200 clinical isolates of Pseudomonas aeruginosa for the detection of 20 drug resistance encoding genes . The Kaohsiung Journal of Medical Sciences 34:2, pages 79-88.
Crossref
Patrick J. BuchananTeng C. LeeVeena VenugopalanElizabeth E. TremblayAnthony P. CannellaMark M. Leyngold. (2018) Extensively Drug-Resistant Pseudomonas aeruginosa Sternal Osteomyelitis. Infectious Diseases in Clinical Practice 26:1, pages 11-15.
Crossref
Manuel Ahumada, Erik J. Suuronen & Emilio I. Alarcon. 2017. Handbook of Ecomaterials. Handbook of Ecomaterials 1 17 .
Mauricio Rodriguez & Salim R. Surani. 2017. Contemporary Topics of Pneumonia. Contemporary Topics of Pneumonia.
Fithamlak Bisetegen Solomon, Fiseha Wadilo, Efrata Girma Tufa & Meseret Mitiku. (2017) Extended spectrum and metalo beta-lactamase producing airborne Pseudomonas aeruginosa and Acinetobacter baumanii in restricted settings of a referral hospital: a neglected condition. Antimicrobial Resistance & Infection Control 6:1.
Crossref
Thanyaluck Siriyong, Potjanee Srimanote, Sasitorn Chusri, Boon-ek Yingyongnarongkul, Channarong Suaisom, Varomyalin Tipmanee & Supayang Piyawan Voravuthikunchai. (2017) Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. BMC Complementary and Alternative Medicine 17:1.
Crossref
Sang-Hun Oh, Hee-Soo Park, Hye-Shin Kim, Jeong-Yul Yun, Kyuman Oh, Young-Lag Cho & Jin-Hwan Kwak. (2017) Antimicrobial activities of LCB10-0200, a novel siderophore cephalosporin, against the clinical isolates of Pseudomonas aeruginosa and other pathogens. International Journal of Antimicrobial Agents 50:6, pages 700-706.
Crossref
M. Gholami, A.S. Chirani, S. Razavi, R. Falak & G. Irajian. (2017) Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from Pseudomonas aeruginosa in mice . Letters in Applied Microbiology 65:5, pages 439-445.
Crossref
Freya Harrison, Alan McNally, Ana C da Silva, Stephan Heeb & Stephen P Diggle. (2017) Optimised chronic infection models demonstrate that siderophore ‘cheating’ in Pseudomonas aeruginosa is context specific. The ISME Journal 11:11, pages 2492-2509.
Crossref
Michael P. Veve, Susan L. Davis, Amy M. Williams, John E. McKinnon & Tamer A. Ghanem. (2017) Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncology 74, pages 181-187.
Crossref
Florian Witzgall, Wiebke Ewert & Wulf Blankenfeldt. (2017) Structures of the N-Terminal Domain of PqsA in Complex with Anthraniloyl- and 6-Fluoroanthraniloyl-AMP: Substrate Activation in Pseudomonas Quinolone Signal (PQS) Biosynthesis . ChemBioChem 18:20, pages 2045-2055.
Crossref
T.L. Tagliaferri, C.D. Vieira, M.A.R. de Carvalho, L.C.D. Ladeira, P.P. Magalhães, L. de Macêdo Farias & S.G. dos Santos. (2017) Phenotypic and genotypic characterization of clinically relevant bacteria isolated from dental waste and waste workers’ hands, mucosas and coats. Letters in Applied Microbiology 65:4, pages 306-312.
Crossref
Pauline Cordenonsi Bonez, Grazielle Guidolin Rossi, Jardel Rodrigo Bandeira, Andiara Prates Ramos, Caren Rigon Mizdal, Vanessa Albertina Agertt, Eloísa Salete Segatto Dalla Nora, Márcia Ebling de Souza, Camilla Fillippi dos Santos Alves, Fallon Siqueira dos Santos, André Gündel, Rodrigo de Almeida Vaucher, Roberto Christ Vianna Santos & Marli Matiko Anraku de Campos. (2017) Anti-biofilm activity of A22 ((S-3,4-dichlorobenzyl) isothiourea hydrochloride) against Pseudomonas aeruginosa: Influence on biofilm formation, motility and bioadhesion. Microbial Pathogenesis 111, pages 6-13.
Crossref
Ami Patel, Antonio DiGiandomenico, Ashley E. Keller, Trevor R. F. Smith, Daniel H. Park, Stephanie Ramos, Katherine Schultheis, Sarah T. C. Elliott, Janess Mendoza, Kate E. Broderick, Megan C. Wise, Jian Yan, Jingjing Jiang, Seleeke Flingai, Amir S. Khan, Kar Muthumani, Laurent Humeau, Lily I. Cheng, Leslie Wachter-Rosati, C. Kendall Stover, Niranjan Y. Sardesai & David B. Weiner. (2017) An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model. Nature Communications 8:1.
Crossref
Warren Chanda, Thomson Joseph, Arshad Padhiar, Xuefang Guo, Liu Min, Wendong Wang, Sainyugu Lolokote, Anhong Ning, Jing Cao, Min Huang & Mintao Zhong. (2017) Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing. Experimental and Therapeutic Medicine.
Crossref
Valjean R. Bacot‐Davis, Angelia V. Bassenden, Tara Sprules & Albert M. Berghuis. (2017) Effect of solvent and protein dynamics in ligand recognition and inhibition of aminoglycoside adenyltransferase 2″‐Ia. Protein Science 26:9, pages 1852-1863.
Crossref
J. Ignacio Barrasa-Villar, Carlos Aibar-Remón, Purificación Prieto-Andrés, Rosa Mareca-Doñate & Javier Moliner-Lahoz. (2017) Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms. Clinical Infectious Diseases 65:4, pages 644-652.
Crossref
Bruna Fuga Araújo, Paola Amaral de Campos, Sabrina Royer, Melina Lorraine Ferreira, Iara Rossi Gonçalves, Deivid William da Fonseca Batistão, Daiane Silva Resende, Cristiane Silveira de Brito, Paulo Pinto Gontijo-Filho & Rosineide Marques Ribas. (2017) High frequency of the combined presence of QRDR mutations and PMQR determinants in multidrug-resistant Klebsiella pneumoniae and Escherichia coli isolates from nosocomial and community-acquired infections. Journal of Medical Microbiology 66:8, pages 1144-1150.
Crossref
Sayyad gholami, Mohammad Tabatabaei & Nasrollah Sohrabi. (2017) Comparison of biofilm formation and antibiotic resistance pattern of Pseudomonas aeruginosa in human and environmental isolates. Microbial Pathogenesis 109, pages 94-98.
Crossref
Ali Pourmand, Maryann Mazer-Amirshahi, Gregory Jasani & Larissa May. (2017) Emerging trends in antibiotic resistance: Implications for emergency medicine. The American Journal of Emergency Medicine 35:8, pages 1172-1176.
Crossref

Displaying 200 of 279 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.